M&A Deal Summary

Thermo Fisher Scientific Acquires MarqMetrix

On June 21, 2023, Thermo Fisher Scientific acquired test/measurement equipment company MarqMetrix

Acquisition Highlights
  • This is Thermo Fisher Scientific’s 11th transaction in the Test/Measurement Equipment sector.
  • This is Thermo Fisher Scientific’s 37th transaction in the United States.
  • This is Thermo Fisher Scientific’s 1st transaction in Washington.

M&A Deal Summary
Date 2023-06-21
Target MarqMetrix
Sector Test/Measurement Equipment
Buyer(s) Thermo Fisher Scientific
Deal Type Add-on Acquisition

Target

MarqMetrix

Seattle, Washington, United States
MarqMetrix provides innovative and fit-for-purpose in-line Process Analytical Technology (PAT), offering customers a simplified method to make precise and accurate measurements throughout the manufacturing process for a wide range of applications, including biopharma and pharmaceuticals, oil and gas, and chemicals and polymers. MarqMetrix was founded in 2012 and is based in Seattle, Washington.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Thermo Fisher Scientific

Waltham, Massachusetts, United States
Category Company
Founded 1956
Sector Test/Measurement Equipment
Employees122,000
Revenue 42.9B USD (2023)
DESCRIPTION
Thermo Fisher's corporate headquarters in Waltham, Massachusetts.
Thermo Fisher's corporate headquarters in Waltham, Massachusetts.

Thermo Scientific is a provider of analytical instruments, laboratory equipment, software, services, consumables and reagents for better workflow solutions spanning sample preparation, sample analysis, and data interpretation. Thermo Fisher Scientific was founded in 1956 and is based in Waltham, Massachusetts.

DEAL STATS #
Overall 60 of 62
Sector (Test/Measurement Equipment) 11 of 11
Type (Add-on Acquisition) 53 of 55
State (Washington) 1 of 1
Country (United States) 37 of 38
Year (2023) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-10-31 Binding Site

Birmingham, United Kingdom

Binding Site is a specialist protein company committed to the research, development, manufacture and distribution of innovative immunodiagnostic assays for the global laboratory market. Binding Site was founded in 1983 and is based in Birmingham, United Kingdom.

Buy £2.3B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-07-06 CorEvitas

Waltham, Massachusetts, United States

CorEvitas provides real-world evidence through syndicated registry data and analysis services, helping biopharmaceutical companies demonstrate the value of their products to clinicians, patients, payers, and regulators. Corona operates six major autoimmune registries across the US, Canada, and Japan, collecting data from over 500 participating investigator sites. CorEvitas was founded in 2001 and is based in Waltham, Massachusetts.

Buy $913M
Mergr

Product

Company

Legal